Designing an Employee Stock Option Plan (ESOP) During an Accelerator: Legal Differences Between Hong Kong and Cayman

The Hong Kong Stock Exchange (HKEX) formally introduced Chapter 18C for Specialist Technology Companies in March 2023, but it was the subsequent update to the Listing Rules in September 2024—specifically the relaxation of the minimum market capitalisation requirement for pre-commercial companies from HKD 10 billion to HKD 8 billion—that has created a tangible pathway for deep-tech and biotech accelerator graduates to pursue a Main Board listing. This regulatory shift, combined with the Securities and Futures Commission’s (SFC) heightened scrutiny of pre-IPO option grants under the Code on Takeovers and Mergers (the Takeovers Code), means that the Employee Stock Option Plan (ESOP) structure chosen during a 12-week accelerator programme is no longer a mere HR formality. For a startup incorporated in the Cayman Islands but preparing for a Hong Kong listing, the legal architecture of the ESOP must reconcile two distinct jurisdictions: the Cayman Islands’ flexible common law framework, which permits broad discretion in option pricing and vesting schedules, and Hong Kong’s prescriptive regime under the Listing Rules, which imposes strict disclosure requirements under Chapter 17 and potential whitewash waiver obligations under Rule 14.06. Founders who treat ESOP design as a secondary consideration during the accelerator phase risk triggering a mandatory general offer under Rule 26 of the Takeovers Code or facing a rejected listing application due to inadequate share scheme disclosures. This article examines the specific legal divergences between Cayman and Hong Kong law in ESOP design, focusing on valuation mechanics, dilution limits, and the treatment of accelerated vesting upon a change of control, drawing on the SFC’s 2025 thematic review of pre-IPO equity plans.

The Jurisdictional Divide: Cayman Flexibility vs. Hong Kong Prescription

The fundamental tension in ESOP design for a Cayman-incorporated, Hong Kong-listed target lies in the Cayman Islands’ absence of statutory restrictions on share option schemes. The Companies Act (as revised) of the Cayman Islands does not prescribe a maximum dilution percentage, a minimum vesting period, or a specific valuation methodology for option grants. This allows a startup in an accelerator to grant options at a nominal exercise price—sometimes as low as USD 0.0001 per share—with immediate vesting upon the occurrence of a liquidity event. However, the Hong Kong Listing Rules, specifically Chapter 17, impose a hard cap of 10% of the issued share capital for any share option scheme, expandable to 30% only with shareholder approval and a detailed justification to the HKEX. The divergence becomes acute when an accelerator graduate seeks to list within three years of incorporation: the HKEX will require a full reconciliation of all option grants made under Cayman law against the Chapter 17 limits, and any grants exceeding the 10% threshold must be fully disclosed in the prospectus (招股書) with a specific explanation of the dilution impact on public shareholders.

Valuation Mechanics: The Fair Value Requirement

Under Cayman law, the board of directors has the discretion to determine the fair value of shares for option pricing, often relying on a 409A valuation (for US tax purposes) or a simple net asset value calculation. The Hong Kong approach, as articulated in HKEX Guidance Letter HKEX-GL112-22 (December 2022), requires that the exercise price of options granted within 12 months of a listing application must not be less than the greater of the IPO offer price or the audited net asset value per share. This creates a specific trap for accelerator-stage companies: a Cayman board may grant options at a nominal price during the programme, but if the company files an A1 listing application within 12 months of that grant, the HKEX will require a top-up payment to the IPO price or a specific waiver application under Rule 17.03(3). The SFC’s 2025 thematic review of pre-IPO equity plans found that 23% of reviewed applications (sample size: 87 companies) had to restructure option grants made within 18 months of listing due to pricing discrepancies between Cayman board resolutions and HKEX requirements.

Dilution Limits and Shareholder Approval

The Cayman Companies Act permits a company to create an unlimited number of authorised shares, subject only to the articles of association. A typical Cayman-incorporated accelerator graduate will have an authorised share capital of USD 50,000 divided into 50 million shares, with the board authorised to issue shares without further shareholder approval. Hong Kong’s Listing Rules, Chapter 17, mandate that any share option scheme must be approved by shareholders in a general meeting, and any material amendment—including an increase in the scheme mandate limit beyond 10%—requires a separate ordinary resolution. The practical consequence for an accelerator graduate is that a Cayman board resolution granting 15% of the post-money equity to employees during the programme will be valid under Cayman law but will violate the Listing Rules upon listing application. The HKEX’s published decisions in 2024 (HKEX Decision HKEX-DEC-2024-06) explicitly rejected two listing applications where the pre-IPO ESOP exceeded 25% of the issued share capital without a specific shareholder resolution, forcing the companies to either cancel the excess options or seek a whitewash waiver under Rule 14.06.

Vesting Schedules and Change of Control Clauses

Accelerator programmes typically impose standard vesting schedules—commonly a four-year monthly vest with a one-year cliff—designed to retain early employees. The Cayman legal framework permits single-trigger acceleration upon a change of control, meaning that all unvested options vest immediately upon a sale of the company. This is standard in venture capital term sheets and is enforceable under Cayman common law. Hong Kong’s Takeovers Code, specifically Rule 26, creates a conflict: if a change of control triggers full vesting, and the resulting option exercise would increase the acquirer’s shareholding above 30%, a mandatory general offer obligation arises unless a whitewash waiver is obtained from the SFC’s Executive. The SFC’s 2024 guidance on the Takeovers Code (SFC-GL-2024-03) clarified that single-trigger acceleration in an ESOP will be treated as a “special deal” under Rule 25, requiring the company to demonstrate that the acceleration is not intended to frustrate a bona fide offer. For accelerator graduates, the recommendation is to adopt double-trigger acceleration (change of control plus termination of employment) to avoid triggering the mandatory offer rules.

The “Good Leaver” and “Bad Leaver” Distinction

Cayman law does not prescribe a statutory distinction between good leaver and bad leaver provisions, leaving this entirely to the option agreement. Hong Kong’s Listing Rules, however, require that any repurchase of options from a “bad leaver” (typically defined as termination for cause) must be at the lower of cost or fair value, and the difference between the exercise price and the market price must be accounted for as a compensation expense under HKFRS 2. The SFC’s 2025 thematic review noted that 17% of reviewed companies had to restate their financial statements because bad leaver provisions in Cayman-governed option agreements did not comply with HKFRS 2 recognition criteria, resulting in a higher-than-reported staff cost in the three years preceding listing. The specific issue arises when a Cayman board repurchases options at par value (e.g., USD 0.0001) from a terminated employee, while the HKEX’s Listing Rules require that the repurchase price reflect the fair value at the date of termination, with the difference recognised as a share-based payment expense.

Tax Implications for Option Exercise

The Cayman Islands imposes no income tax, capital gains tax, or withholding tax on the exercise of share options, making it a tax-neutral jurisdiction for option holders. Hong Kong, by contrast, treats the gain from option exercise (the difference between the market price and the exercise price at the date of exercise) as assessable income under Section 9 of the Inland Revenue Ordinance (Cap. 112), subject to salaries tax at progressive rates up to 17%. For a Hong Kong-resident employee of an accelerator graduate, the tax liability arises at the point of exercise, not at the point of grant, creating a cash-flow problem if the shares are not immediately tradable. The HKEX’s Listing Rules require that the prospectus disclose the maximum tax liability for a Hong Kong-resident option holder assuming full exercise at the IPO price, and the company must confirm that it has no obligation to satisfy the employee’s tax liability. The practical implication for accelerator founders is that a Cayman-governed ESOP with a low exercise price (e.g., USD 0.01) will generate a large taxable gain upon listing, potentially exceeding the employee’s cash resources. The HKEX’s 2024 guidance on share schemes (HKEX-GL112-22) recommends that companies consider a cashless exercise mechanism or a share withholding arrangement to address this cash-flow issue, but neither is standard in Cayman option agreements.

Regulatory Filings and Disclosure Obligations

The Cayman Islands requires no public filing of an ESOP or any amendment to it, provided the company is not listed on the Cayman Islands Stock Exchange (CSX). A Cayman board resolution adopting an ESOP is a private document, and the company’s register of members is not publicly accessible. Hong Kong’s Listing Rules, Chapter 17, require that every share option scheme must be filed with the HKEX as a “scheme document” within 15 business days of adoption, and any material amendment—including a change in the exercise price or vesting schedule—requires a separate filing and shareholder approval. The HKEX’s 2025 consultation paper on share schemes (published March 2025) proposed extending the filing requirement to all pre-IPO option grants made within 24 months of the listing application, not just the scheme itself. For an accelerator graduate, this means that option grants made during the programme—potentially two to three years before listing—will be subject to HKEX disclosure if the company files an A1 application within that 24-month window. The SFC’s 2025 thematic review found that 31% of reviewed companies had to retrospectively file option grant details that were not originally documented in the Cayman board minutes, because the HKEX required a complete audit trail of all grants made within the 24-month lookback period.

The Whitewash Waiver Process

If an ESOP grants options to a director or a substantial shareholder (holding 10% or more of the voting rights), the exercise of those options may trigger a mandatory general offer under Rule 26 of the Takeovers Code. The SFC’s Executive can grant a whitewash waiver under Rule 26.2, but only if the company demonstrates that the option grant was made on normal commercial terms and that the exercise price is not less than the market price at the time of grant. For accelerator-stage companies, where there is no market price, the SFC requires an independent valuation from a qualified valuer (typically a Big Four accounting firm or a licensed investment bank) to establish that the exercise price is at fair market value. The SFC’s 2024 guidance (SFC-GL-2024-03) specifies that a valuation based on the company’s last round of funding (e.g., a Series A at a USD 10 million post-money valuation) will be accepted only if the option grant is made within six months of that round. For options granted during an accelerator programme that precedes the first institutional round by 12-18 months, the SFC will require a standalone valuation that considers the company’s stage-specific risk factors, including the probability of failure (typically 50-70% for pre-revenue startups) and the lack of a secondary market. The cost of this valuation—ranging from HKD 80,000 to HKD 200,000 per valuation—is a direct expense that accelerator graduates must budget for in their pre-IPO planning.

Prospectus Disclosure Requirements

The HKEX’s Listing Rules, Chapter 11, require that the prospectus include a detailed description of every share option scheme, including the total number of options granted, exercised, and outstanding, the exercise price range, and the vesting schedule for each grant. The SFC’s Code on Share Buy-backs (which applies to option repurchases) requires that the prospectus disclose the maximum dilution that could result from full exercise of all outstanding options, expressed as a percentage of the post-IPO issued share capital. For a Cayman-incorporated company, the prospectus must also disclose any differences between Cayman law and Hong Kong law that could affect the enforceability of the option agreements, specifically the absence of statutory shareholder approval requirements under Cayman law. The HKEX’s published listing decisions in 2024 (HKEX-DEC-2024-12) rejected one application where the prospectus did not disclose that the ESOP was governed by Cayman law and that Hong Kong’s statutory protections under the Employment Ordinance (Cap. 57) did not apply to option grants, because the options were considered equity instruments rather than wages. The practical takeaway for accelerator graduates is that the prospectus must include a specific section titled “Differences in Share Option Regime Between Cayman Islands and Hong Kong,” which is not standard in Cayman-incorporated company prospectuses and requires additional legal drafting time (typically 2-4 weeks).

Actionable Takeaways for Accelerator Founders

1. Adopt a double-trigger vesting clause in the ESOP (change of control plus termination of employment) to avoid triggering a mandatory general offer under Rule 26 of the Takeovers Code, which would require a costly whitewash waiver application to the SFC.
2. Cap the ESOP mandate at 10% of the post-money issued share capital during the accelerator phase, even if Cayman law permits a higher percentage, because the HKEX will require shareholder approval and a detailed prospectus disclosure for any scheme exceeding this threshold under Chapter 17.
3. Set the exercise price at fair market value based on the most recent institutional round valuation, and document this valuation in the board minutes, because the HKEX requires a minimum exercise price of the higher of the IPO offer price or net asset value for grants made within 12 months of listing.
4. Include a cashless exercise mechanism or a share withholding arrangement in the option agreement to address the cash-flow tax liability for Hong Kong-resident employees, who will be subject to salaries tax under Section 9 of the Inland Revenue Ordinance upon exercise.
5. Retain a Hong Kong-licensed lawyer to review the ESOP before the accelerator programme ends, because the 24-month lookback period for HKEX disclosure means that option grants made during the programme will be subject to full regulatory scrutiny upon listing application.